Drug Pricing
Approach online weight-loss drug offers with skepticism
If you’ve spent any time on social media lately, you’ve probably seen the ads. Lose weight fast. Get access to GLP-1s. Skip the doctor’s office. Delivered right to your door. For millions of Americans looking to lose weight, the promise is…
Don’t Blame Breakthrough Drugs for Costs, Fix…
America’s healthcare tab has hit a new record. According to federal data published late last month,…
PBM’s Drug Cut Exceeds the Total Cost of Medicines In…
Another fundamental problem is these comparisons rely on U.S. medicines’ gross (or list) price. But…
Congress should fulfill this drug program’s…
A federal program intended to help low-income patients has instead become a major revenue source for…
This Drug Patent Bill Would Hurt Innovation Without…
This week, the Senate Committee on Health, Education, Labor and Pensions will consider several bills…
Unauthorized GLP-1 Knockoffs Risk Patient Safety and Future Innovation, New PRI Brief Warns
As federal regulators intensify enforcement against companies selling unauthorized knockoffs of blockbuster weight-loss drugs, a new Pacific Research Institute brief warns that the booming GLP-1 knockoff market is creating patient safety risks while…
Big Medical Breakthroughs Start With Small Gains
That may not sound like much. For someone facing a terminal diagnosis, what difference does a few…
It’s Time For Congress To Get 340B Out Of Its Blind…
If a charity organization collected billions of dollars with little evidence that needy people…
Trump Puts Drug Pricing Program Fraudsters on Notice
The Trump administration is ramping up its fight against waste, fraud, and abuse in healthcare. And…
TRENDING
